| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
6e-05 |
| mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |